Gene · 5590
Papers4,064
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 4,064
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Neutrophil Extracellular Traps in Diabetic Kidney Disease: Mechanisms of Pathogenesis and Emerging Therapeutic Strategies. | Drug Des Devel Ther | 2026 | 41756312 | PubTator, text mining | PubMed |
| Organoids Gone Viral: A Comprehensive Review on Human Organoid Models to Study Viral Pathogenesis. | Viruses | 2026 | 41754581 | PubTator, text mining | PubMed |
| Posidonia oceanica (L.) Delile in Focus: In Vitro and In Vivo Evidence for Biomedical Potential. | Int J Mol Sci | 2026 | 41751863 | PubTator, text mining | PubMed |
| The Role of Raf Kinase Inhibitor Protein (RKIP) in HER2+ Breast Cancer Immune Evasion. | Cells | 2026 | 41744762 | PubTator, text mining | PubMed |
| Comprehensive Clinical, Diagnostic, and In Silico Assessment of a Novel 1p36.33p36.32 Copy Number Variant. | J Cell Mol Med | 2026 | 41738692 | PubTator, text mining | PubMed |
| Biliopancreatic diversion with duodenal switch improve polycystic ovary syndrome with decreased serum ceramides. | Front Endocrinol (Lausanne) | 2026 | 41727679 | PubTator, text mining | PubMed |
| The Acid sphingomyelinase/ceramide System in Idiopathic Inflammatory Myopathies: a Potential Treatment Target. | Inflammation | 2026 | 41721077 | PubTator, text mining | PubMed |
| Pulpitis as a microbial disease: single-cell insights into host responses and diagnostic biomarkers for vital pulp therapy. | J Oral Microbiol | 2026 | 41717505 | PubTator, text mining | PubMed |
| Anti-cancer effect of palmitic acid against the endometrial cancer progression via inducing ferroptosis. | Biochem Biophys Rep | 2026 | 41717082 | PubTator, text mining | PubMed |
| Post-translational regulation of human D-3-phosphoglycerate dehydrogenase in Alzheimer's disease. | Protein Sci | 2026 | 41711160 | PubTator, text mining | PubMed |
| Ceramide metabolism in oxidative and glycolytic muscle: Significance for lipid-induced insulin resistance. | Mol Metab | 2026 | 41707846 | PubTator, text mining | PubMed |
| PKC-eta promotes breast cancer metastasis by regulating the Hippo-YAP signaling pathway. | Signal Transduct Target Ther | 2026 | 41698898 | PubTator, text mining | PubMed |
| Assessing reference ranges for non-HLA antibodies: Comparative analysis of blood donors and kidney transplant candidates. | Transpl Immunol | 2026 | 41692072 | PubTator, text mining | PubMed |
| High resolution genome-wide SNP array analyses on matched colorectal-based lung and brain metastases. | J Cancer Res Clin Oncol | 2026 | 41615482 | PubTator, text mining | PubMed |
| Utilization of machine learning algorithms for the identification of the RLN associated prognostic model and feature biomarkers of RLN-related subtypes in breast cancer. | Transl Oncol | 2026 | 41581316 | PubTator, text mining | PubMed |
| Hypercapnia Effects on Lung Function. | Compr Physiol | 2026 | 41578665 | PubTator, text mining | PubMed |
| Enhanced nuclear localization of small heterodimer partner in metabolic dysfunction-associated steatohepatitis. | JHEP Rep | 2026 | 41438338 | PubTator, text mining | PubMed |
| Post-Transcriptional Modification Integration for Ligand-Receptor Cellular Network Inference. | Mol Cell Proteomics | 2026 | 41423050 | PubTator, text mining | PubMed |
| Protein kinase C zeta promotes thyroid Cancer progression and represents a novel therapeutic target: evidence from specific atypical PKC inhibitor 2-acetyl-1,3-cyclopentanedione inhibitor studies. | Front Med (Lausanne) | 2025 | 41608434 | PubTator, text mining | PubMed |
| Comprehensive and In-Depth Molecular and Pathway Studies of the Hippocampus in Alzheimer's Disease. | Cell Mol Neurobiol | 2025 | 41317176 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5590/papers?page=2